| Large-scale characterization of drug responses of clinically relevant proteins in cancer cell lines W Zhao, J Li, MJM Chen, Y Luo, Z Ju, NK Nesser, K Johnson-Camacho, ... Cancer cell 38 (6), 829-843. e4, 2020 | 55 | 2020 |
| RBMS1 suppresses colon cancer metastasis through targeted stabilization of its mRNA regulon J Yu, A Navickas, H Asgharian, B Culbertson, L Fish, K Garcia, ... Cancer discovery 10 (9), 1410-1423, 2020 | 43 | 2020 |
| Single-cell profiling of tumor immune microenvironment reveals immune irresponsiveness in gastric signet-ring cell carcinoma J Chen, K Liu, Y Luo, M Kang, J Wang, G Chen, J Qi, W Wu, B Wang, ... Gastroenterology 165 (1), 88-103, 2023 | 41 | 2023 |
| A mast cell–thermoregulatory neuron circuit axis regulates hypothermia in anaphylaxis C Bao, O Chen, H Sheng, J Zhang, Y Luo, BW Hayes, H Liang, W Liedtke, ... Science immunology 8 (81), eadc9417, 2023 | 36 | 2023 |
| Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma Z Zhou, MJM Chen, Y Luo, K Mojumdar, X Peng, H Chen, SV Kumar, ... Cancer Cell 40 (11), 1324-1340. e8, 2022 | 27 | 2022 |
| Cxxc finger protein 1 positively regulates GM-CSF-derived macrophage phagocytosis through Csf2rα-mediated signaling Z Hui, L Zhou, Z Xue, L Zhou, Y Luo, F Lin, X Liu, S Hong, W Li, D Wang, ... Frontiers in immunology 9, 1885, 2018 | 18 | 2018 |
| RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells X Peng, Y Luo, H Li, X Guo, H Chen, X Ji, H Liang PLoS genetics 18 (3), e1010130, 2022 | 16 | 2022 |
| Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors Y Luo, Y Xia, D Liu, X Li, H Li, J Liu, D Zhou, Y Dong, X Li, Y Qian, C Xu, ... Cell 187 (18), 4905-4925. e24, 2024 | 14 | 2024 |
| Cxxc finger protein 1 maintains homeostasis and function of intestinal group 3 innate lymphoid cells with aging X Shen, X Gao, Y Luo, Q Xu, Y Fan, S Hong, Z Huang, X Liu, Q Wang, ... Nature Aging 3 (8), 965-981, 2023 | 11 | 2023 |
| Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment W Lin, Y Luo, J Wu, H Zhang, G Jin, C Guo, H Zhou, H Liang, X Xu Journal for immunotherapy of cancer 11 (11), 2023 | 10 | 2023 |
| Single-cell dissection of tumor microenvironmental response and resistance to cancer therapy Y Luo, H Liang Trends in Genetics, 2023 | 9 | 2023 |
| Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors C Kim, XD Wang, Z Liu, J Hao, S Wang, P Li, Z Zi, Q Ding, S Jang, J Kim, ... Science Advances 10 (3), eadh2579, 2024 | 5 | 2024 |
| Cancer cells employ the most prolific RNA editors: a closer look at the single-cell level Y Luo, H Liang Cancer Research 83 (3), 351-353, 2023 | 1 | 2023 |
| Convergent Usage of Amino Acids in Human Cancers as A Reversed Process of Tissue Development Y Luo, H Liang Genomics, Proteomics and Bioinformatics 20 (1), 147-162, 2022 | 1 | 2022 |
| Developmental-status-aware transcriptional decomposition establishes a cell state panorama of human cancers Y Luo, H Liang Genome medicine 16 (1), 124, 2024 | | 2024 |
